Sanjana Bhattarai Pandey
Family · Canton, OHNPI 1417722497
Payments from drug & device makers
Across 40 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$120
- Lilly USA, LLC$73
- Corcept Therapeutics$55
- Amgen$51
- Insulet Corporation$47
- Boehringer Ingelheim$42
- plus $415 from 18 others
What the payments were for
- Food & beverage$804100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $120 |
| Lilly USA, LLC | 4 | $73 |
| Corcept Therapeutics | 2 | $55 |
| Amgen | 2 | $51 |
| Insulet Corporation | 2 | $47 |
| Boehringer Ingelheim | 3 | $42 |
| Ascendis Pharma Endocrinology Inc | 2 | $41 |
| Globus Medical | 1 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Abbott | 2 | $31 |
| Medtronic | 1 | $26 |
| Tandem Diabetes Care, Inc. | 2 | $24 |
| Novartis | 1 | $24 |
| Nevro Corp. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
| Evoke Pharma, Inc. | 1 | $20 |
| AbbVie | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| BETA Bionics, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
How this compares
$804 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 96 | $90,074 |
| OzempicSemaglutide | 64 | $87,436 |
| TrulicityDulaglutide | 47 | $54,459 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $24,191 |
| Tresiba Flextouch U-100Insulin Degludec | 37 | $20,130 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 19 | $18,618 |
| MounjaroTirzepatide | 13 | $17,889 |
| TradjentaLinagliptin | 22 | $17,630 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $17,000 |
| HumalogInsulin Lispro | 23 | $10,058 |
| Humalog Kwikpen U-100Insulin Lispro | 40 | $9,325 |
| VascepaIcosapent Ethyl | 13 | $9,142 |
| FarxigaDapagliflozin Propanediol | 18 | $8,926 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 41 | $7,335 |
| Novolog FlexpenInsulin Aspart | 14 | $5,343 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $42 | $107,704118 claims |
| Novo NordiskOzempic | $120 | $87,43664 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $73 | $83,75194 claims |
| AbbVieSynthroid | $20 | $1,82514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,812 family providers in Ohio.
Other family in Canton
- Brittany McClainCanton$17K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.